Sign in
Taking peopleNo phase

PET/CT scans using MET or FET tracers in glioma and parathyroid disease

Tests PET/CT imaging to find tumor lesions in adults with amino acid transporter diseases.

Key facts

Who runs it
Tianjin Medical University
Where
China3 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
Status
Recruiting
People taking part
500 people, planned
Started
29 Aug 2013
Expected to end
29 Aug 2033
Type of study
Observational
Treatments tested
  • 11C/18F-MET/FET
Record updated
8 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a suspected, new or previously treated cancer who have a planned amino acid PET/CT scan (11C/18F-MET/FET).

Age
18 Years to 90 Years
Sex
All sexes
Disease stage
Suspected, newly diagnosed or previously treated malignant tumors, primary or spread (metastatic) lesions.
Earlier treatment
People with no prior treatment and people already treated can both join.

Main reasons for not taking part

  • Lesions that are not cancer
  • Pregnancy
  • Unable or unwilling to give written informed consent

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • adult patients (aged 18 years or order)
  • patients with suspected or newly diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report)
  • patients who had scheduled AATS PET/CT scan
  • patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee

Who cannot take part

  • patients with non-malignant lesions
  • patients with pregnancy
  • the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the potential usefulness of 11C/18F-MET/FET positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various amino acid transporter system (AATS)-related disease patients.

The group in the trial

  • Single Group Assignment

    Each subject receive a single intravenous injection of 11C/18F-MET/FET, and undergo PET/CT imaging within the specificed time.

    Treatment: 11C/18F-MET/FET

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
Plain-language title
PET/CT scans using MET or FET tracers in glioma and parathyroid diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07379463, who can take part
Record updated
8 September 2026